Eikon Therapeutics
Erin Sanders is a Scientist in Cell Biology at Bruker Cellular Analysis since March 2023, specializing in Antibody Discovery and T cell workflows on the Beacon® platform. Previously, Erin held a similar role at Berkeley Lights from September 2021 to March 2023, where the Opto® Memory B Discovery Rabbit Workflow was launched to enhance antibody diversity. Erin earned a Ph.D. in Developmental Biology from Stanford University, where research focused on adult Drosophila intestinal stem cells under the O'Brien lab. Additional experience includes roles as a Program Assistant at Stanford ADVANCE Summer Institute, a Junior Specialist at De Tomaso Lab at UCSB, and positions at Monsanto and UC Davis Plant Sciences. Erin holds a Bachelor of Science in Biochemistry and Molecular Biology from UC Santa Barbara.
This person is not in any teams
Eikon Therapeutics
3 followers
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.